Patents by Inventor Douglas N. Ludtke

Douglas N. Ludtke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • STABLE SOLID ORAL DOSAGE CO-FORMULATIONS
    Publication number: 20110189297
    Abstract: Pharmaceutical compositions are provided that can act as boosters to improve the pharmacokinetics of drugs that undergo in vivo degradation by cytochrome P450 enzymes. Methods of inhibiting cytochrome P450 enzymes are provided that can be used for improving the treatment of diseases by preventing degradation of drugs or other molecules by cytochrome P450. Specifically, methods of inhibiting metabolic degradation of atazanavir sulphate for administering to a patient suffering from HIV infection are disclosed.
    Type: Application
    Filed: September 16, 2009
    Publication date: August 4, 2011
    Applicant: Sequicia Pharmaceuticals
    Inventors: Douglas N. Ludtke, Raymond E. Dagger
  • Use of antisense oligomers in a process for controlling contamination in nucleic acid amplification reactions
    Patent number: 5763186
    Abstract: A novel process for the use of antisense oligonucleotides and analogs thereof has been developed. Namely, this technique is useful for the elimination of contamination in the nucleic acid amplification area. Elimination of unwanted contamination has made gene probe analyses much more reproduceable.
    Type: Grant
    Filed: January 3, 1997
    Date of Patent: June 9, 1998
    Assignee: Chiron Diagnostics Corporation
    Inventors: Douglas N. Ludtke, John E. Monahan, John T. Unger